Aga Khan Award for Architecture announces 2022 Master Jury to select recipients of $1m prize

1
197

The members of the Master Jury for the 2020-2022 Cycle of the Aga Khan Award for Architecture were announced last month.

The Jury, which independently selects the recipients of the US$ 1 million Award, will convene in January 2022 to select a shortlist from hundreds of nominated projects, according to a statement released by AKDN.

Once the Master Jury selects a shortlist, the shortlisted projects are then subjected to rigorous on-site reviews by independent experts, most of them architects, conservation specialists, planners or structural engineers.

The Jury will meet for a second time in summer 2022 to examine the on-site reviews and select the final recipients of the Award.

The selection process emphasises architecture that not only provides for people’s physical, social and economic needs, but that also stimulates and responds to their cultural aspirations.

Particular attention is given to building schemes that use local resources and appropriate technology in innovative ways and to projects likely to inspire similar efforts elsewhere.

The Aga Khan Award for Architecture is governed by a Steering Committee chaired by His Highness the Aga Khan.

The other members of the Steering Committee are Sheikha Mai Bint Mohammed Al Khalifa, President, Bahrain Authority for Culture and Antiquities, Manama; Emre Arolat, Founder, EAA – Emre Arolat Architecture, Istanbul; Meisa Batayneh, Principal Architect, Founder, maisam architects and engineers, Amman; Sir David Chipperfield, Principal, David Chipperfield Architects, London; Souleymane Bachir Diagne, Director, Institute of African Studies, Columbia University, New York; Nasser Rabbat, Aga Khan Professor, Massachusetts Institute of Technology, Cambridge; Marina Tabassum, Principal, Marina Tabassum Architects, Dhaka; Sarah M. Whiting, Dean, Graduate School of Design, Harvard University, Cambridge. Farrokh Derakhshani is the Director of the Award.

Advertisement

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here